Symmetric Bis-chalcones as a New Type of Breast Cancer Resistance Protein Inhibitors with a Mechanism Different from That of Chromones

Journal of Medicinal Chemistry
2014.0

Abstract

Potent ABCG2 inhibitors were recently identified as asymmetric chromones with different types of substituents. We here synthesized symmetric bis-chalcones that were differently substituted and screened for their ability to inhibit mitoxantrone efflux from ABCG2-transfected HEK293 cells. Potent bis-chalcone inhibitors were identified, the efficiency depending on both position of the central ketone groups and the number and positions of lateral methoxy substituents. The best derivative, namely, 1p, was selective for ABCG2 over P-glycoprotein and MRP1, appeared not to be transported by ABCG2, and was at least as active on various drug-selected cancer cells overexpressing ABCG2. Compound 1p stimulated the ABCG2 basal ATPase activity by contrast to a chromone lead that inhibited it, suggesting different mechanisms of interaction. Combination of both types of inhibitors produced synergistic effects, leading to complete inhibition at very low concentrations.

Knowledge Graph

Similar Paper

Symmetric Bis-chalcones as a New Type of Breast Cancer Resistance Protein Inhibitors with a Mechanism Different from That of Chromones
Journal of Medicinal Chemistry 2014.0
Structure–Activity Relationships of Chromone Derivatives toward the Mechanism of Interaction with and Inhibition of Breast Cancer Resistance Protein ABCG2
Journal of Medicinal Chemistry 2013.0
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)
European Journal of Medicinal Chemistry 2016.0
Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein
Bioorganic & Medicinal Chemistry 2008.0
Piperazinobenzopyranones and Phenalkylaminobenzopyranones:  Potent Inhibitors of Breast Cancer Resistance Protein (ABCG2)
Journal of Medicinal Chemistry 2005.0
Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2)
European Journal of Medicinal Chemistry 2017.0
Acridone derivatives: Design, synthesis, and inhibition of breast cancer resistance protein ABCG2
Bioorganic & Medicinal Chemistry 2007.0
4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)
Journal of Medicinal Chemistry 2017.0
Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)
Journal of Medicinal Chemistry 2016.0
Synthesis and Investigation of Tetrahydro-β-carboline Derivatives as Inhibitors of the Breast Cancer Resistance Protein (ABCG2)
Journal of Medicinal Chemistry 2016.0